Abnormal distribution of hDlg and PTEN in premalignant lesions and invasive cervical cancer
Por:
Vázquez-Ulloa E., Lizano M., Avilés-Salas A., Alfaro-Moreno E., Contreras-Paredes A.
Publicada:
1 sep 2011
Resumen:
Objective. The aim of the present study was to evaluate differences in expression levels and localization status of PTEN, p53 and hDlg suppressor proteins in premalignant lesions and cervical cancer, and to analyze the possible correlation between them. Methods. Expression levels (positivity/intensity) and localization (nuclear, membrane or cytoplasmic) of PTEN, hDlg and p53 were analyzed by immunohistochemistry in 43 cases with different stages of cervical intraepithelial neoplasia (CIN) and 105 invasive cervical carcinomas (ICC) (91 squamous carcinoma, 14 adenocarcinoma). Differences between proportions were evaluated. Results. We found a decreased expression of PTEN in ICC that correlated with a loss of hDlg from the cell membrane. In contrast, no changes were found in p53 protein levels or localization in CIN and ICC. Conclusions. These results suggest that the abnormal expression and localization of PTEN during cervical carcinogenesis may be a consequence of modifications in the e
Filiaciones:
Vázquez-Ulloa E.:
Univ Nacl Autonoma Mexico, Unidad Invest Biomed Canc, Inst Nacl Cancerol, Inst Invest Biomed, Tlalpan 14080, Mexico
Lizano M.:
Univ Nacl Autonoma Mexico, Unidad Invest Biomed Canc, Inst Nacl Cancerol, Inst Invest Biomed, Tlalpan 14080, Mexico
Avilés-Salas A.:
Departamento de Patología Quirúrgica, Instituto Nacional de Cancerología, Mexico
Alfaro-Moreno E.:
Univ Nacl Autonoma Mexico, Unidad Invest Biomed Canc, Inst Nacl Cancerol, Inst Invest Biomed, Tlalpan 14080, Mexico
Contreras-Paredes A.:
Univ Nacl Autonoma Mexico, Unidad Invest Biomed Canc, Inst Nacl Cancerol, Inst Invest Biomed, Tlalpan 14080, Mexico
|